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Acute myocardial infarction is a rare event in a patient with a left ventricular
assist device (LVAD). We present a case of ST-segment elevation myocardial
infarction in a LVAD patient.
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A 53 year-old male with a HeartMate II (Thoratec Corporation, Pleasanton, CA)
left ventricular assist device (LVAD) presented to an outside emergency
department with acute onset of chest pain. LVAD placement occurred 5 months
prior to patient’s presentation due to end-stage ischemic cardiomyopathy. The
patient’s history was significant for refractory gastrointestinal bleeding while on
LVAD support which resulted in complete cessation of all anticoagulation
including aspirin. ECG demonstrated significant ST elevation in the anterior
leads. The patient was given aspirin and started on intravenous heparin and
transferred to our institution for urgent left heart catheterization. Catheterization
showed 100% thrombotic occlusion of the mid left anterior descending artery
(Figure 1). Aspiration thrombectomy and percutaneous transluminal coronary
angioplasty were performed with successful result and minimal residual disease
(Figure 2). Mild to moderate disease was found elsewhere consistent with his
history of known ischemic heart failure. The patient was loaded with 600 mg of
clopidogrel. Chest pain completely resolved.
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Fig 1. Total left anterior descending artery occlusion on coronary
angiogram. Video at: https://vimeo.com/130852738

Fig 2. Restoration of flow in left anterior descending artery following
successful thrombectomy and angioplasty.
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However, the day following the procedure, the patient developed acute onset of
right facial droop, expressive aphasia, and right-sided weakness. Emergent
head CT with angiography showed a thrombus within the left middle cerebral
artery (M1 segment). Urgent cerebral angiography was performed and the
patient underwent successful mechanical thrombectomy of the left middle
cerebral artery with restoration of 85% of the left middle cerebral circulation. The
patient’s neurological status dramatically improved.
Both of these events appeared to be embolic in nature, possibly
contributed by the patient’s lack of anticoagulation. Upon admission, lactate
dehydrogenase (LDH) was elevated at 466 U/L compared to 232 U/L 1 month
prior to admission. Free hemoglobin was elevated as well at 45 mg/dL.
Transthoracic echocardiogram showed no visible thrombus in left ventricular
cavity and Doppler velocities through inflow cannula were normal. Parameters
were normal on LVAD interrogation and no power spikes were noted.
Given that he had no active signs of gastrointestinal bleeding, the patient
was started on intravenous heparin and warfarin and aspirin were also initiated.
The patient did well initially with continued improvement in his neurological
deficits. However eight days after admission to the hospital, he developed new
aphasia and hemiparesis once again. Urgent head CT showed the new
development of an intraparenchymal hematoma centered in the temporal lobe
with mild mass effect. The patient was not believed to be a candidate for
neurosurgical intervention. As a result, anticoagulation was stopped, including
clopidogrel. Despite the new neurological insult, over the next several days the
patient once again was improving from a neurological standpoint. However, 16
days following hospital admission, his mental status acutely deteriorated and he
became unresponsive. Head CT showed a new acute infarction in the right
middle cerebral artery territory. Given his general poor prognosis, the family
elected to proceed with comfort measures and he died on hospitalization day
#20. The family declined autopsy, and the LVAD was not sent to the
manufacturer.
Acute myocardial infarction following LVAD implantation is a rare
phenomenon. The latest annual INTERMACS report showed that myocardial
infraction occurred in the first 12 months after LVAD implant at a rate of 0.08
events per 100 patient-months.1 Compared to other adverse events such as
bleeding, right heart failure, arrhythmias, and infection, myocardial infarction is
far less common. ST-segment elevation myocardial infarction has been reported
in an LVAD patient soon after implant due to thrombotic occlusion of the left
coronary cusp.2 In the present case, we hypothesize that our patient’s myocardial
infarction and stroke were likely embolic events from a thrombus in the blood
pump pathway. The exact location of the thrombus was not certain. LDH and
free hemoglobin were both elevated, but other LVAD parameters including power
were normal. However, it is well known that LDH can often be the only sign of
impending LVAD thrombosis.3 Lack of anticoagulation due to refractory
gastrointestinal bleeding likely was the major factor contributing to thrombus
formation. Recent data suggests that rates of LVAD thrombosis are increasing
and clinicians should be aware that acute myocardial infarction may be evidence
of this complication.4 We hope that this case report adds awareness to this
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potential complication which may become more common as patients are living
longer with continuous-flow LVADs.
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